CEREVEL THERAPEUTICS HLDNG I

CUSIP: 15678U128 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 1,469,670 Value ($000) $60,111 Avg Close Range
Q1 2024
Shares 1,874,387 Value ($000) $79,243 Avg Close Range
Q4 2023
Shares 1,789,302 Value ($000) $75,876 Avg Close Range
Q3 2023
Shares 1,439,277 Value ($000) $31,423 Avg Close Range
Q2 2023
Shares 1,346,029 Value ($000) $42,790 Avg Close Range
Q1 2023
Shares 1,257,920 Value ($000) $30,681 Avg Close Range
Q4 2022
Shares 1,204,108 Value ($000) $38 Avg Close Range
Q3 2022
Shares 1,134,261 Value ($000) $32,054 Avg Close Range
Q2 2022
Shares 1,052,290 Value ($000) $27,822 Avg Close Range
Q1 2022
Shares 925,701 Value ($000) $32,408 Avg Close Range
Q4 2021
Shares 928,773 Value ($000) $30,110 Avg Close Range
Q3 2021
Shares 909,115 Value ($000) $26,818 Avg Close Range
Q2 2021
Shares 752,427 Value ($000) $19,277 Avg Close Range
Q1 2021
Shares 443,791 Value ($000) $6,093 Avg Close Range
Q4 2020
Shares 458,783 Value ($000) $7,606 Avg Close Range